SCHEMBL30846341

SCHEMBL30846341

Cc1ccc(-c2ccc(S(=O)(=O)Nc3cccc4cnn(C)c34)cn2)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC40A1 Q9NP59 11/20 0.41
▸ KMT2A Q03164 5/20 0.41
▸ TDP1 Q9NUW8 4/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ AGTR1 P30556 2/20 0.41
▸ MITF O75030 1/20 0.41
▸ S1PR4 O95977 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ S1PR1 P21453 1/20 0.41
▸ OPRK1 P41145 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ CKS1B P61024 1/20 0.41
▸ SKP2 Q13309 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ GLO1 Q04760 5/20 0.39
▸ PAX8 Q06710 1/20 0.39
▸ PIK3CA P42336 1/20 0.37
▸ KIT P10721 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27118142 1.00 SLC40A1 (0.41) SLC40A1KMT2ATDP1MEN1AGTR1
SCHEMBL27118195 0.91 SLC40A1 (0.40) SLC40A1KMT2ATDP1MEN1AGTR1
SCHEMBL30846276 0.91 SLC40A1 (0.40) SLC40A1KMT2ATDP1MEN1AGTR1
SCHEMBL27119245 0.89 GAA (0.48) SLC40A1KMT2AMEN1ALDH1A1LMNA
SCHEMBL30846288 0.89 GAA (0.38) SLC40A1KMT2ATDP1MEN1AGTR1
SCHEMBL27118277 0.89 GAA (0.38) SLC40A1KMT2ATDP1MEN1AGTR1
SCHEMBL27118016 0.88 SLC40A1 (0.48) SLC40A1KMT2ATDP1MEN1AGTR1
SCHEMBL30846443 0.88 SLC40A1 (0.48) SLC40A1KMT2ATDP1MEN1AGTR1
SCHEMBL30846475 0.87 SLC40A1 (0.41) SLC40A1KMT2ATDP1MEN1AGTR1
SCHEMBL30846255 0.87 EIF2AK3 (0.48) SLC40A1LMNAMAPTGLO1PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044344-A1 PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback